EyePoint Pharmaceuticals
EYPT
EYPT
36 hedge funds and large institutions have $30.1M invested in EyePoint Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 30 → 36 (+6)
Holders
36
Holding in Top 10
–
Calls
$2.43M
Puts
$1.55M
Top Buyers
| 1 | +$5.61M | |
| 2 | +$745K | |
| 3 | +$619K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$159K |
| 5 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
+$96K |
Top Sellers
| 1 | -$889K | |
| 2 | -$650K | |
| 3 | -$599K | |
| 4 |
Renaissance Technologies
New York
|
-$226K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$188K |